Another stem cell court victory

Even though California started linkurl:distributing stem cell funding;http://www.the-scientist.com/blog/display/52856/ this month, the California Institute for Regenerative Medicine (CIRM) is still fighting for its survival in court. On Monday (February 26), a state appeals court upheld a linkurl:2006 verdict;http://www.the-scientist.com/news/display/23342/-legal verdict by a lower court judge, who said the organization was did not violate the constitution. But opponents of the California stem

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Even though California started linkurl:distributing stem cell funding;http://www.the-scientist.com/blog/display/52856/ this month, the California Institute for Regenerative Medicine (CIRM) is still fighting for its survival in court. On Monday (February 26), a state appeals court upheld a linkurl:2006 verdict;http://www.the-scientist.com/news/display/23342/-legal verdict by a lower court judge, who said the organization was did not violate the constitution. But opponents of the California stem cell agency linkurl:vow to keep tying it up;http://news.yahoo.com/s/ap/20070227/ap_on_re_us/stem_cell_lawsuits;_ylt=AiqL58IDX._wYcoRr3ebJ_SJhMgF in court, and said they plan to appeal to the state Supreme Court. In the latest episode of a drama worthy of Court TV, Robert N. Klein, chairman of the governing board for the state agency that manages CIRM, said in linkurl:a statement;http://www.cirm.ca.gov/pressreleases/2007/02/02-14-07a.asp after both sides presented their cases that "In the eyes of seven million Californian voters and the Alameda County Superior Court, Proposition 71 is constitutional? The opponents we faced in court today continue to ignore that very clear mandate." Klein also proclaimed that, by March 15, $130 million in Proposition 71 stem cell research funding will be in place for California scientists. Meanwhile, the agency is running on loans, which it can't pay back until the court cases are resolved. A handful of CIRM opponents argue the organization is not constitutional. The majority of California voters approve of its mandate. Do you have an opinion? You can post your comments here.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Alison McCook

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide